Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by investment analysts at UBS Group from $39.00 to $42.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group‘s price target would indicate a potential upside of 14.16% from the stock’s previous close.
Several other equities research analysts also recently issued reports on KDP. Morgan Stanley lifted their price target on shares of Keurig Dr Pepper from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Wednesday. BNP Paribas Exane upped their price objective on shares of Keurig Dr Pepper from $28.00 to $29.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. HSBC upgraded Keurig Dr Pepper from a “hold” rating to a “buy” rating and boosted their price target for the stock from $37.00 to $40.00 in a research note on Thursday, August 13th. Bank of America increased their price target on Keurig Dr Pepper from $35.00 to $38.00 in a report on Friday, July 10th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Keurig Dr Pepper in a research note on Friday, August 7th. Ten equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Keurig Dr Pepper has a consensus rating of “Moderate Buy” and an average price target of $37.12.
Read Our Latest Stock Analysis on KDP
Keurig Dr Pepper Trading Up 5.9%
KDP traded up $2.05 on Wednesday, reaching $36.79. 28,586,576 shares of the company’s stock were exchanged, compared to its average volume of 12,304,528. Keurig Dr Pepper has a twelve month low of $24.88 and a twelve month high of $37.31. The company’s 50 day moving average is $32.58 and its 200-day moving average is $30.07. The company has a market cap of $50.06 billion, a price-to-earnings ratio of 37.16, a PEG ratio of 1.75 and a beta of 0.35. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.28 and a current ratio of 0.48.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. The business had revenue of $7.34 billion for the quarter, compared to the consensus estimate of $7.33 billion. Keurig Dr Pepper had a net margin of 7.10% and a return on equity of 10.80%. The business’s revenue for the quarter was up 70.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.54 EPS. Equities analysts predict that Keurig Dr Pepper will post 2.30 earnings per share for the current year.
Insider Buying and Selling
In other Keurig Dr Pepper news, VP Angela A. Stephens sold 9,500 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the sale, the vice president directly owned 55,786 shares in the company, valued at approximately $1,824,202.20. This trade represents a 14.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Aaron E. Alt purchased 7,862 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, August 25th. The shares were purchased at an average cost of $31.83 per share, with a total value of $250,247.46. Following the acquisition, the director owned 7,862 shares of the company’s stock, valued at approximately $250,247.46. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. 0.34% of the stock is owned by company insiders.
Institutional Trading of Keurig Dr Pepper
Hedge funds have recently bought and sold shares of the company. AlphaCore Capital LLC grew its position in Keurig Dr Pepper by 58.8% in the 3rd quarter. AlphaCore Capital LLC now owns 20,196 shares of the company’s stock worth $613,000 after purchasing an additional 7,476 shares during the last quarter. Retirement Systems of Alabama increased its stake in shares of Keurig Dr Pepper by 664.0% in the third quarter. Retirement Systems of Alabama now owns 2,183,609 shares of the company’s stock valued at $66,251,000 after purchasing an additional 1,897,787 shares during the period. Fulcrum Asset Management LLP increased its stake in shares of Keurig Dr Pepper by 1,691.7% in the third quarter. Fulcrum Asset Management LLP now owns 3,225 shares of the company’s stock valued at $100,000 after purchasing an additional 3,045 shares during the period. Brighton Jones LLC raised its holdings in shares of Keurig Dr Pepper by 4.4% during the third quarter. Brighton Jones LLC now owns 38,525 shares of the company’s stock valued at $1,169,000 after buying an additional 1,634 shares during the last quarter. Finally, Candriam S.C.A. raised its holdings in shares of Keurig Dr Pepper by 1.5% during the third quarter. Candriam S.C.A. now owns 152,232 shares of the company’s stock valued at $4,636,000 after buying an additional 2,316 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors.
More Keurig Dr Pepper News
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst expectations, while revenue of $7.34 billion edged past estimates. Earnings grew from $0.54 a year earlier, supported by beverage growth and the JDE Peet’s acquisition. The company reaffirmed its 2026 outlook. Keurig Dr Pepper Q3 results
- Positive Sentiment: JPMorgan raised its price target to $41 and maintained an Overweight rating. Morgan Stanley also raised its target, to $40, and kept an Overweight rating; Piper Sandler lifted its target to $41. These moves indicate continued analyst optimism. JPMorgan price-target update Piper Sandler price-target update
- Positive Sentiment: The company’s energy-drink market share topped 10% following recent brand acquisitions, offering another potential growth engine alongside its established beverage businesses. Long-term investor takeaways
- Neutral Sentiment: TD Cowen raised its price target to $35 but retained a Hold rating, signaling a more cautious view than the Overweight calls. TD Cowen price-target update
- Negative Sentiment: KDP warned that U.S. coffee profitability may slow in the fourth quarter as consumers trade down, a near-term headwind that tempers the strong headline results. Report on fourth-quarter coffee profits
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.
The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Featured Articles
- Five stocks we like better than Keurig Dr Pepper
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
